AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue Repair | AVITA Medical
- Forums
- ASX - By Stock
- AVH
- FDA Breakthrough Device Designations for VITILIGO & Soft Tissue for the RECELL® System
FDA Breakthrough Device Designations for VITILIGO & Soft Tissue for the RECELL® System, page-39
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.99 |
Change
-0.080(2.61%) |
Mkt cap ! $204.2M |
Open | High | Low | Value | Volume |
$3.05 | $3.06 | $2.97 | $1.015M | 338.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 3441 | $2.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.00 | 2747 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 2240 | 2.990 |
4 | 8043 | 2.980 |
5 | 15442 | 2.970 |
7 | 34332 | 2.960 |
5 | 35018 | 2.950 |
Price($) | Vol. | No. |
---|---|---|
3.000 | 2256 | 2 |
3.010 | 7547 | 1 |
3.020 | 4714 | 3 |
3.030 | 14700 | 4 |
3.040 | 1422 | 2 |
Last trade - 14.56pm 18/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |